Stoke Therapeutics names Thomas McCauley as chief scientific officer
Go back to Stoke Therapeutics names Thomas McCauley as chief scientific officer| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.15 +1.72 (0.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $215.43 | 52 Week High | $333.65 | |||
| Open | $216.75 | 52 Week Low | $223.02 | |||
| Day High | $219.76 | P/E | 27.80 | |||
| Day Low | $214.71 | EPS | $7.81 | |||
| Volume | 1,075,561 | |||||
| (NASDAQ: STOK) | Delayed: 29.03 -0.31 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.34 | 52 Week High | $ | |||
| Open | $29.82 | 52 Week Low | $ | |||
| Day High | $30.16 | P/E | N/A | |||
| Day Low | $29.01 | EPS | $ | |||
| Volume | 600,709 | |||||
